{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T05:21:27Z","timestamp":1783488087584,"version":"3.55.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T00:00:00Z","timestamp":1730073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T00:00:00Z","timestamp":1730073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 DK-017047"],"award-info":[{"award-number":["P30 DK-017047"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 ES-007033"],"award-info":[{"award-number":["P30 ES-007033"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 ES-007033"],"award-info":[{"award-number":["P30 ES-007033"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 DK-017047"],"award-info":[{"award-number":["P30 DK-017047"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 DK-089507"],"award-info":[{"award-number":["P30 DK-089507"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008871","name":"Juvenile Diabetes Research Foundation United States of America","doi-asserted-by":"publisher","award":["5-SRA-2018-557-Q-R"],"award-info":[{"award-number":["5-SRA-2018-557-Q-R"]}],"id":[{"id":"10.13039\/100008871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008871","name":"Juvenile Diabetes Research Foundation United States of America","doi-asserted-by":"publisher","award":["5-SRA-2018-557-Q-R"],"award-info":[{"award-number":["5-SRA-2018-557-Q-R"]}],"id":[{"id":"10.13039\/100008871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007028","name":"Leona M. and Harry B. Helmsley Charitable Trust","doi-asserted-by":"publisher","award":["2018PG-T1D053, G-2108-04793"],"award-info":[{"award-number":["2018PG-T1D053, G-2108-04793"]}],"id":[{"id":"10.13039\/100007028","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007028","name":"Leona M. and Harry B. Helmsley Charitable Trust","doi-asserted-by":"publisher","award":["2018PG-T1D053, G-2108-04793"],"award-info":[{"award-number":["2018PG-T1D053, G-2108-04793"]}],"id":[{"id":"10.13039\/100007028","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-76722-1","type":"journal-article","created":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T08:43:52Z","timestamp":1730105032000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Cystic fibrosis-related diabetes is associated with reduced islet protein expression of GLP-1 receptor and perturbation of cell-specific transcriptional programs"],"prefix":"10.1038","volume":"14","author":[{"given":"Sina A.","family":"Gharib","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachna","family":"Vemireddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph J.","family":"Castillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendy S.","family":"Fountaine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theo K.","family":"Bammler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James W.","family":"MacDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca L.","family":"Hull-Meichle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakeneh","family":"Zraika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,28]]},"reference":[{"key":"76722_CR1","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.2337\/dc09-0586","volume":"32","author":"A Moran","year":"2009","unstructured":"Moran, A. et al. Cystic fibrosis-related diabetes: current trends in prevalence, incidence, and mortality. Diabetes Care. 32, 1626\u20131631. https:\/\/doi.org\/10.2337\/dc09-0586 (2009).","journal-title":"Diabetes Care"},{"key":"76722_CR2","unstructured":"Cystic Fibrosis Foundation Patient Registry 2021 Annual Data Report. Bethesda, Maryland, USA. Cystic Fibrosis Foundation. (2022)."},{"key":"76722_CR3","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1164\/rccm.201403-0576OC","volume":"191","author":"C Lewis","year":"2015","unstructured":"Lewis, C. et al. Diabetes-related mortality in adults with cystic fibrosis. Role of genotype and sex. Am. J. Respir Crit. Care Med.\u00a0191, 194\u2013200. https:\/\/doi.org\/10.1164\/rccm.201403-0576OC (2015).","journal-title":"Am. J. Respir Crit. Care Med."},{"key":"76722_CR4","doi-asserted-by":"publisher","first-page":"100286","DOI":"10.1016\/j.jcte.2021.100286","volume":"27","author":"L Merjaneh","year":"2022","unstructured":"Merjaneh, L., Hasan, S., Kasim, N. & Ode, K. L. The role of modulators in cystic fibrosis related diabetes. J. Clin. Transl Endocrinol.\u00a027, 100286. https:\/\/doi.org\/10.1016\/j.jcte.2021.100286 (2022).","journal-title":"J. Clin. Transl Endocrinol."},{"key":"76722_CR5","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.1210\/clinem\/dgab365","volume":"106","author":"A Kelly","year":"2021","unstructured":"Kelly, A. et al. Effect of sitagliptin on islet function in pancreatic insufficient cystic fibrosis with abnormal glucose tolerance. J. Clin. Endocrinol. Metab.\u00a0106, 2617\u20132634. https:\/\/doi.org\/10.1210\/clinem\/dgab365 (2021).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"76722_CR6","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.2337\/db22-0399","volume":"71","author":"SC Nyirjesy","year":"2022","unstructured":"Nyirjesy, S. C. et al. Effects of GLP-1 and GIP on islet function in glucose-intolerant, pancreatic-insufficient cystic fibrosis. Diabetes. 71, 2153\u20132165. https:\/\/doi.org\/10.2337\/db22-0399 (2022).","journal-title":"Diabetes"},{"key":"76722_CR7","doi-asserted-by":"publisher","unstructured":"Gnanapragasam, H., Mustafa, N., Bierbrauer, M., Providence, A., Dandona, P. & T. & Semaglutide in cystic fibrosis-related diabetes. J. Clin. Endocrinol. Metab.\u00a0105.\u00a0https:\/\/doi.org\/10.1210\/clinem\/dgaa167 (2020).","DOI":"10.1210\/clinem\/dgaa167"},{"key":"76722_CR8","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1369\/jhc.2008.951319","volume":"56","author":"D Tornehave","year":"2008","unstructured":"Tornehave, D., Kristensen, P., Romer, J., Knudsen, L. B. & Heller, R. S. Expression of the GLP-1 receptor in mouse, rat, and human pancreas. J. Histochem. Cytochem.\u00a056, 841\u2013851. https:\/\/doi.org\/10.1369\/jhc.2008.951319 (2008).","journal-title":"J. Histochem. Cytochem."},{"key":"76722_CR9","doi-asserted-by":"publisher","first-page":"3018","DOI":"10.1210\/en.2011-0286","volume":"152","author":"A Waget","year":"2011","unstructured":"Waget, A. et al. Physiological and pharmacological mechanisms through which the DPP-4 inhibitor sitagliptin regulates glycemia in mice. Endocrinology. 152, 3018\u20133029. https:\/\/doi.org\/10.1210\/en.2011-0286 (2011).","journal-title":"Endocrinology"},{"key":"76722_CR10","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.brainres.2010.05.002","volume":"1344","author":"MC Washington","year":"2010","unstructured":"Washington, M. C., Raboin, S. J., Thompson, W., Larsen, C. J. & Sayegh, A. I. Exenatide reduces food intake and activates the enteric nervous system of the gastrointestinal tract and the dorsal vagal complex of the hindbrain in the rat by a GLP-1 receptor. Brain Res.\u00a01344, 124\u2013133. https:\/\/doi.org\/10.1016\/j.brainres.2010.05.002 (2010).","journal-title":"Brain Res."},{"key":"76722_CR11","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1210\/jcem.80.3.7883856","volume":"80","author":"CF Deacon","year":"1995","unstructured":"Deacon, C. F., Johnsen, A. H. & Holst, J. J. Degradation of glucagon-like peptide-1 by human plasma in vitro yields an N-terminally truncated peptide that is a major endogenous metabolite in vivo. J. Clin. Endocrinol. Metab.\u00a080, 952\u2013957. https:\/\/doi.org\/10.1210\/jcem.80.3.7883856 (1995).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"76722_CR12","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.2337\/diab.44.9.1126","volume":"44","author":"CF Deacon","year":"1995","unstructured":"Deacon, C. F. et al. Both subcutaneously and intravenously administered glucagon-like peptide I are rapidly degraded from the NH2-terminus in type II diabetic patients and in healthy subjects. Diabetes. 44, 1126\u20131131 (1995).","journal-title":"Diabetes"},{"key":"76722_CR13","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/S0196-9781(97)00123-X","volume":"18","author":"K Hupe-Sodmann","year":"1997","unstructured":"Hupe-Sodmann, K. et al. Endoproteolysis of glucagon-like peptide (GLP)-1 (7\u201336) amide by ectopeptidases in RINm5F cells. Peptides. 18, 625\u2013632 (1997).","journal-title":"Peptides"},{"key":"76722_CR14","doi-asserted-by":"crossref","unstructured":"Hupe-Sodmann, K. et al. Characterisation of the processing by human neutral endopeptidase 24.11 of GLP-1(7\u201336) amide and comparison of the substrate specificity of the enzyme for other glucagon-like peptides. Regul. Pept.\u00a058, 149\u2013156. 016701159500063H [pii] (1995).","DOI":"10.1016\/0167-0115(95)00063-H"},{"key":"76722_CR15","doi-asserted-by":"publisher","first-page":"3585","DOI":"10.1210\/endo.136.8.7628397","volume":"136","author":"TJ Kieffer","year":"1995","unstructured":"Kieffer, T. J., McIntosh, C. H. & Pederson, R. A. Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV. Endocrinology. 136, 3585\u20133596. https:\/\/doi.org\/10.1210\/endo.136.8.7628397 (1995).","journal-title":"Endocrinology"},{"key":"76722_CR16","doi-asserted-by":"publisher","first-page":"934775","DOI":"10.3389\/fendo.2022.934775","volume":"13","author":"MM Holter","year":"2022","unstructured":"Holter, M. M., Saikia, M. & Cummings, B. P. Alpha-cell paracrine signaling in the regulation of beta-cell insulin secretion. Front. Endocrinol. (Lausanne). 13, 934775. https:\/\/doi.org\/10.3389\/fendo.2022.934775 (2022).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"76722_CR17","doi-asserted-by":"publisher","unstructured":"Capozzi, M. E. et al. Beta cell tone is defined by proglucagon peptides through cAMP signaling. JCI Insight. 4.\u00a0https:\/\/doi.org\/10.1172\/jci.insight.126742 (2019).","DOI":"10.1172\/jci.insight.126742"},{"key":"76722_CR18","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1007\/s001250051484","volume":"43","author":"P Huypens","year":"2000","unstructured":"Huypens, P., Ling, Z., Pipeleers, D. & Schuit, F. Glucagon receptors on human islet cells contribute to glucose competence of insulin release. Diabetologia. 43, 1012\u20131019. https:\/\/doi.org\/10.1007\/s001250051484 (2000).","journal-title":"Diabetologia"},{"key":"76722_CR19","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/S0140-6736(65)90761-0","volume":"2","author":"E Samols","year":"1965","unstructured":"Samols, E., Marri, G. & Marks, V. Promotion of insulin secretion by glucagon. Lancet. 2, 415\u2013416 (1965).","journal-title":"Lancet"},{"key":"76722_CR20","doi-asserted-by":"publisher","unstructured":"Svendsen, B. et al. Insulin secretion depends on intra-islet glucagon signaling. Cell Rep.\u00a025,\u00a01127\u20131134 e1122 (2018). https:\/\/doi.org\/10.1016\/j.celrep.2018.10.018","DOI":"10.1016\/j.celrep.2018.10.018"},{"key":"76722_CR21","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1210\/me.2004-0350","volume":"19","author":"K Masur","year":"2005","unstructured":"Masur, K., Tibaduiza, E. C., Chen, C., Ligon, B. & Beinborn, M. Basal receptor activation by locally produced glucagon-like peptide-1 contributes to maintaining beta-cell function. Mol. Endocrinol.\u00a019, 1373\u20131382. https:\/\/doi.org\/10.1210\/me.2004-0350 (2005).","journal-title":"Mol. Endocrinol."},{"key":"76722_CR22","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/j.1365-2362.1992.tb01464.x","volume":"22","author":"R Eissele","year":"1992","unstructured":"Eissele, R. et al. Glucagon-like peptide-1 cells in the gastrointestinal tract and pancreas of rat, pig and man. Eur. J. Clin. Invest.\u00a022, 283\u2013291 (1992).","journal-title":"Eur. J. Clin. Invest."},{"key":"76722_CR23","doi-asserted-by":"publisher","first-page":"3262","DOI":"10.1007\/s00125-012-2716-9","volume":"55","author":"P Marchetti","year":"2012","unstructured":"Marchetti, P. et al. A local glucagon-like peptide 1 (GLP-1) system in human pancreatic islets. Diabetologia. 55, 3262\u20133272. https:\/\/doi.org\/10.1007\/s00125-012-2716-9 (2012).","journal-title":"Diabetologia"},{"key":"76722_CR24","doi-asserted-by":"publisher","first-page":"8001","DOI":"10.1016\/S0021-9258(19)39030-1","volume":"265","author":"S Mojsov","year":"1990","unstructured":"Mojsov, S., Kopczynski, M. G. & Habener, J. F. Both amidated and nonamidated forms of glucagon-like peptide I are synthesized in the rat intestine and the pancreas. J. Biol. Chem.\u00a0265, 8001\u20138008 (1990).","journal-title":"J. Biol. Chem."},{"key":"76722_CR25","doi-asserted-by":"publisher","first-page":"13468","DOI":"10.1073\/pnas.0600655103","volume":"103","author":"RD Wideman","year":"2006","unstructured":"Wideman, R. D. et al. Improving function and survival of pancreatic islets by endogenous production of glucagon-like peptide 1 (GLP-1). Proc. Natl. Acad. Sci. U S A. 103, 13468\u201313473. https:\/\/doi.org\/10.1073\/pnas.0600655103 (2006).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"76722_CR26","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1093\/bioinformatics\/btq401","volume":"26","author":"D Wu","year":"2010","unstructured":"Wu, D. et al. Roast: Rotation gene set tests for complex microarray experiments.\u00a0Bioinformatics. 26, 2176\u20132182. https:\/\/doi.org\/10.1093\/bioinformatics\/btq401 (2010).","journal-title":"Bioinformatics"},{"key":"76722_CR27","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jcf.2014.06.004","volume":"14","author":"L Merjaneh","year":"2015","unstructured":"Merjaneh, L., He, Q., Long, Q., Phillips, L. S. & Stecenko, A. A. Disposition index identifies defective beta-cell function in cystic fibrosis subjects with normal glucose tolerance. J. Cyst. Fibros.\u00a014, 135\u2013141. https:\/\/doi.org\/10.1016\/j.jcf.2014.06.004 (2015).","journal-title":"J. Cyst. Fibros."},{"key":"76722_CR28","doi-asserted-by":"publisher","first-page":"134","DOI":"10.2337\/db16-0394","volume":"66","author":"S Sheikh","year":"2017","unstructured":"Sheikh, S. et al. Reduced beta-cell secretory capacity in pancreatic-insufficient, but not pancreatic-sufficient, cystic fibrosis despite normal glucose tolerance. Diabetes. 66, 134\u2013144. https:\/\/doi.org\/10.2337\/db16-0394 (2017).","journal-title":"Diabetes"},{"key":"76722_CR29","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1111\/j.1464-5491.2009.02738.x","volume":"26","author":"K Mohan","year":"2009","unstructured":"Mohan, K. et al. Mechanisms of glucose intolerance in cystic fibrosis. Diabet. Med.\u00a026, 582\u2013588. https:\/\/doi.org\/10.1111\/j.1464-5491.2009.02738.x (2009).","journal-title":"Diabet. Med."},{"key":"76722_CR30","doi-asserted-by":"publisher","first-page":"17231","DOI":"10.1038\/s41598-017-17404-z","volume":"7","author":"M Bogdani","year":"2017","unstructured":"Bogdani, M. et al. Structural abnormalities in islets from very young children with cystic fibrosis may contribute to cystic fibrosis-related diabetes. Sci. Rep.\u00a07, 17231. https:\/\/doi.org\/10.1038\/s41598-017-17404-z (2017).","journal-title":"Sci. Rep."},{"key":"76722_CR31","doi-asserted-by":"publisher","first-page":"823","DOI":"10.2337\/dc17-1387","volume":"41","author":"RL Hull","year":"2018","unstructured":"Hull, R. L. et al. Islet interleukin-1beta immunoreactivity is an early feature of cystic fibrosis that may contribute to beta-cell failure. Diabetes Care. 41, 823\u2013830. https:\/\/doi.org\/10.2337\/dc17-1387 (2018).","journal-title":"Diabetes Care"},{"key":"76722_CR32","doi-asserted-by":"publisher","unstructured":"Hart, N. J. et al. Cystic fibrosis-related diabetes is caused by islet loss and inflammation. JCI Insight. 3.\u00a0https:\/\/doi.org\/10.1172\/jci.insight.98240 (2018).","DOI":"10.1172\/jci.insight.98240"},{"key":"76722_CR33","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/BF00718598","volume":"414","author":"M Lohr","year":"1989","unstructured":"Lohr, M. et al. Cystic fibrosis associated islet changes may provide a basis for diabetes. An immunocytochemical and morphometrical study. Virchows Arch. Pathol. Anat. Histopathol. 414, 179\u2013185 (1989).","journal-title":"Virchows Arch. Pathol. Anat. Histopathol"},{"key":"76722_CR34","doi-asserted-by":"publisher","first-page":"101014","DOI":"10.1016\/j.molmet.2020.101014","volume":"39","author":"SA Campbell","year":"2020","unstructured":"Campbell, S. A. et al. Human islets contain a subpopulation of glucagon-like peptide-1 secreting alpha cells that is increased in type 2 diabetes. Mol. Metab.\u00a039, 101014. https:\/\/doi.org\/10.1016\/j.molmet.2020.101014 (2020).","journal-title":"Mol. Metab."},{"key":"76722_CR35","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1530\/JOE-11-0094","volume":"211","author":"NM Whalley","year":"2011","unstructured":"Whalley, N. M., Pritchard, L. E., Smith, D. M. & White, A. Processing of proglucagon to GLP-1 in pancreatic alpha-cells: is this a paracrine mechanism enabling GLP-1 to act on beta-cells? J. Endocrinol.\u00a0211, 99\u2013106. https:\/\/doi.org\/10.1530\/JOE-11-0094 (2011).","journal-title":"J. Endocrinol."},{"key":"76722_CR36","doi-asserted-by":"publisher","first-page":"4514","DOI":"10.1210\/en.2005-0402","volume":"146","author":"R McGirr","year":"2005","unstructured":"McGirr, R. et al. Glucose dependence of the regulated secretory pathway in alphaTC1-6 cells. Endocrinology. 146, 4514\u20134523. https:\/\/doi.org\/10.1210\/en.2005-0402 (2005).","journal-title":"Endocrinology"},{"key":"76722_CR37","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1038\/nm.2513","volume":"17","author":"H Ellingsgaard","year":"2011","unstructured":"Ellingsgaard, H. et al. Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells. Nat. Med.\u00a017, 1481\u20131489. https:\/\/doi.org\/10.1038\/nm.2513 (2011).","journal-title":"Nat. Med."},{"key":"76722_CR38","doi-asserted-by":"publisher","first-page":"149","DOI":"10.4161\/isl.2.3.11396","volume":"2","author":"G Kilimnik","year":"2010","unstructured":"Kilimnik, G., Kim, A., Steiner, D. F., Friedman, T. C. & Hara, M. Intraislet production of GLP-1 by activation of prohormone convertase 1\/3 in pancreatic alpha-cells in mouse models of ss-cell regeneration. Islets. 2, 149\u2013155. https:\/\/doi.org\/10.4161\/isl.2.3.11396 (2010).","journal-title":"Islets"},{"key":"76722_CR39","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1172\/JCI7456","volume":"105","author":"Y Nie","year":"2000","unstructured":"Nie, Y. et al. Regulation of pancreatic PC1 and PC2 associated with increased glucagon-like peptide 1 in diabetic rats. J. Clin. Invest.\u00a0105, 955\u2013965. https:\/\/doi.org\/10.1172\/JCI7456 (2000).","journal-title":"J. Clin. Invest."},{"key":"76722_CR40","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3109\/15513818609025923","volume":"6","author":"K Soejima","year":"1986","unstructured":"Soejima, K. & Landing, B. H. Pancreatic islets in older patients with cystic fibrosis with and without diabetes mellitus: morphometric and immunocytologic studies. Pediatr. Pathol.\u00a06, 25\u201346 (1986).","journal-title":"Pediatr. Pathol."},{"key":"76722_CR41","doi-asserted-by":"publisher","unstructured":"Hansen, A. M. et al. Upregulation of alpha cell glucagon-like peptide 1 (GLP-1) in Psammomys obesus\u2013an adaptive response to hyperglycaemia? Diabetologia.\u00a054, 1379\u20131387 (2011). https:\/\/doi.org\/10.1007\/s00125-011-2080-1","DOI":"10.1007\/s00125-011-2080-1"},{"key":"76722_CR42","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1002\/dmrr.2534","volume":"30","author":"TJ O\u2019Malley","year":"2014","unstructured":"O\u2019Malley, T. J., Fava, G. E., Zhang, Y., Fonseca, V. A. & Wu, H. Progressive change of intra-islet GLP-1 production during diabetes development. Diabetes Metab. Res. Rev.\u00a030, 661\u2013668. https:\/\/doi.org\/10.1002\/dmrr.2534 (2014).","journal-title":"Diabetes Metab. Res. Rev."},{"key":"76722_CR43","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.1093\/hmg\/ddp178","volume":"18","author":"L Shu","year":"2009","unstructured":"Shu, L. et al. Decreased TCF7L2 protein levels in type 2 diabetes mellitus correlate with downregulation of GIP- and GLP-1 receptors and impaired beta-cell function. Hum. Mol. Genet.\u00a018, 2388\u20132399. https:\/\/doi.org\/10.1093\/hmg\/ddp178 (2009).","journal-title":"Hum. Mol. Genet."},{"key":"76722_CR44","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1210\/en.2013-1934","volume":"155","author":"C Pyke","year":"2014","unstructured":"Pyke, C. et al. GLP-1 receptor localization in monkey and human tissue: novel distribution revealed with extensively validated monoclonal antibody. Endocrinology. 155, 1280\u20131290. https:\/\/doi.org\/10.1210\/en.2013-1934 (2014).","journal-title":"Endocrinology"},{"key":"76722_CR45","doi-asserted-by":"publisher","unstructured":"Recino, A. et al. GLP-1R is downregulated in beta cells of NOD mice and T1D patients. bioRxiv, 845776 (2019). https:\/\/doi.org\/10.1101\/845776","DOI":"10.1101\/845776"},{"key":"76722_CR46","doi-asserted-by":"publisher","first-page":"e129954","DOI":"10.1172\/jci.insight.129954","volume":"5","author":"ME Capozzi","year":"2019","unstructured":"Capozzi, M. E. et al. Glucagon lowers glycemia when beta-cells are active. JCI Insight. 5, e129954. https:\/\/doi.org\/10.1172\/jci.insight.129954 (2019).","journal-title":"JCI Insight"},{"key":"76722_CR47","doi-asserted-by":"publisher","first-page":"101484","DOI":"10.1016\/j.jbc.2021.101484","volume":"298","author":"O Cabrera","year":"2022","unstructured":"Cabrera, O. et al. Intra-islet glucagon confers beta-cell glucose competence for first-phase insulin secretion and favors GLP-1R stimulation by exogenous glucagon. J. Biol. Chem.\u00a0298, 101484. https:\/\/doi.org\/10.1016\/j.jbc.2021.101484 (2022).","journal-title":"J. Biol. Chem."},{"key":"76722_CR48","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.3390\/cells10092495","volume":"10","author":"Y Zhang","year":"2021","unstructured":"Zhang, Y. et al. Glucagon potentiates insulin secretion via beta-cell GCGR at physiological concentrations of glucose. Cells. 10, 2495. https:\/\/doi.org\/10.3390\/cells10092495 (2021).","journal-title":"Cells"},{"key":"76722_CR49","doi-asserted-by":"publisher","first-page":"66","DOI":"10.2337\/diab.47.1.66","volume":"47","author":"K Moens","year":"1998","unstructured":"Moens, K. et al. Dual glucagon recognition by pancreatic beta-cells via glucagon and glucagon-like peptide 1 receptors. Diabetes. 47, 66\u201372. https:\/\/doi.org\/10.2337\/diab.47.1.66 (1998).","journal-title":"Diabetes"},{"key":"76722_CR50","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s00125-012-2776-x","volume":"56","author":"ZF Kang","year":"2013","unstructured":"Kang, Z. F. et al. Pharmacological reduction of NEFA restores the efficacy of incretin-based therapies through GLP-1 receptor signalling in the beta cell in mouse models of diabetes. Diabetologia. 56, 423\u2013433. https:\/\/doi.org\/10.1007\/s00125-012-2776-x (2013).","journal-title":"Diabetologia"},{"key":"76722_CR51","doi-asserted-by":"publisher","first-page":"e230335","DOI":"10.1530\/JOE-23-0335","volume":"261","author":"AI Oqua","year":"2024","unstructured":"Oqua, A. I. et al. Lipid regulation of the glucagon receptor family. J. Endocrinol.\u00a0261, e230335. https:\/\/doi.org\/10.1530\/JOE-23-0335 (2024).","journal-title":"J. Endocrinol."},{"key":"76722_CR52","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/0092-8674(94)90296-8","volume":"78","author":"JA Braks","year":"1994","unstructured":"Braks, J. A. & Martens, G. J. 7B2 is a neuroendocrine chaperone that transiently interacts with prohormone convertase PC2 in the secretory pathway. Cell. 78, 263\u2013273. https:\/\/doi.org\/10.1016\/0092-8674(94)90296-8 (1994).","journal-title":"Cell"},{"key":"76722_CR53","doi-asserted-by":"publisher","first-page":"3242","DOI":"10.1073\/pnas.91.8.3242","volume":"91","author":"Y Rouille","year":"1994","unstructured":"Rouille, Y., Westermark, G., Martin, S. K. & Steiner, D. F. Proglucagon is processed to glucagon by prohormone convertase PC2 in alpha TC1-6 cells. Proc. Natl. Acad. Sci. USA. 91, 3242\u20133246. https:\/\/doi.org\/10.1073\/pnas.91.8.3242 (1994).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"76722_CR54","doi-asserted-by":"publisher","first-page":"534","DOI":"10.2337\/diabetes.50.3.534","volume":"50","author":"J Wang","year":"2001","unstructured":"Wang, J. et al. The prohormone convertase enzyme 2 (PC2) is essential for processing pro-islet amyloid polypeptide at the NH2-terminal cleavage site. Diabetes. 50, 534\u2013539. https:\/\/doi.org\/10.2337\/diabetes.50.3.534 (2001).","journal-title":"Diabetes"},{"key":"76722_CR55","doi-asserted-by":"publisher","first-page":"107761","DOI":"10.1016\/j.celrep.2020.107761","volume":"31","author":"K Viloria","year":"2020","unstructured":"Viloria, K. et al. Vitamin-D-binding protein contributes to the maintenance of alpha cell function and glucagon secretion. Cell. Rep.\u00a031, 107761. https:\/\/doi.org\/10.1016\/j.celrep.2020.107761 (2020).","journal-title":"Cell. Rep."},{"key":"76722_CR56","doi-asserted-by":"publisher","first-page":"L476","DOI":"10.1152\/ajplung.00262.2006","volume":"292","author":"NM White","year":"2007","unstructured":"White, N. M. et al. Altered cholesterol homeostasis in cultured and in vivo models of cystic fibrosis. Am. J. Physiol. Lung Cell. Mol. Physiol.\u00a0292, L476\u2013486. https:\/\/doi.org\/10.1152\/ajplung.00262.2006 (2007).","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"76722_CR57","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1165\/rcmb.2004-0117OC","volume":"31","author":"NM White","year":"2004","unstructured":"White, N. M., Corey, D. A. & Kelley, T. J. Mechanistic similarities between cultured cell models of cystic fibrosis and niemann-pick type C. Am. J. Respir Cell. Mol. Biol.\u00a031, 538\u2013543. https:\/\/doi.org\/10.1165\/rcmb.2004-0117OC (2004).","journal-title":"Am. J. Respir Cell. Mol. Biol."},{"key":"76722_CR58","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1172\/JCI33296","volume":"118","author":"LR Brunham","year":"2008","unstructured":"Brunham, L. R., Kruit, J. K., Verchere, C. B. & Hayden, M. R. Cholesterol in islet dysfunction and type 2 diabetes. J. Clin. Invest.\u00a0118, 403\u2013408. https:\/\/doi.org\/10.1172\/JCI33296 (2008).","journal-title":"J. Clin. Invest."},{"key":"76722_CR59","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1210\/en.2018-00004","volume":"159","author":"LL Baggio","year":"2018","unstructured":"Baggio, L. L. et al. GLP-1 receptor expression within the human heart. Endocrinology. 159, 1570\u20131584. https:\/\/doi.org\/10.1210\/en.2018-00004 (2018).","journal-title":"Endocrinology"},{"key":"76722_CR60","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1210\/en.2012-2124","volume":"154","author":"C Pyke","year":"2013","unstructured":"Pyke, C. & Knudsen, L. B. The glucagon-like peptide-1 receptor\u2013or not? Endocrinology. 154, 4\u20138. https:\/\/doi.org\/10.1210\/en.2012-2124 (2013).","journal-title":"Endocrinology"},{"key":"76722_CR61","doi-asserted-by":"publisher","unstructured":"Muraro, M. J. et al. A single-cell transcriptome atlas of the human pancreas. Cell Syst.\u00a03, 385\u2013394 e383 (2016). https:\/\/doi.org\/10.1016\/j.cels.2016.09.002","DOI":"10.1016\/j.cels.2016.09.002"},{"key":"76722_CR62","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.cmet.2016.08.020","volume":"24","author":"A Segerstolpe","year":"2016","unstructured":"Segerstolpe, A. et al. Single-cell transcriptome profiling of human pancreatic islets in health and type 2 diabetes. Cell. Metab.\u00a024, 593\u2013607. https:\/\/doi.org\/10.1016\/j.cmet.2016.08.020 (2016).","journal-title":"Cell. Metab."},{"key":"76722_CR63","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of Fold change and dispersion for RNA-seq data with DESeq2. Genome Biol.\u00a015, 550. https:\/\/doi.org\/10.1186\/s13059-014-0550-8 (2014).","journal-title":"Genome Biol."},{"key":"76722_CR64","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA. 102, 15545\u201315550. https:\/\/doi.org\/10.1073\/pnas.0506580102 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-76722-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-76722-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-76722-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T09:04:54Z","timestamp":1730365494000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-76722-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,28]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["76722"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-76722-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,28]]},"assertion":[{"value":"16 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"25689"}}